Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques

Citation
T. Steinhoff et al., Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques, NEUROBIOL D, 8(4), 2001, pp. 647-654
Citations number
30
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROBIOLOGY OF DISEASE
ISSN journal
09699961 → ACNP
Volume
8
Issue
4
Year of publication
2001
Pages
647 - 654
Database
ISI
SICI code
0969-9961(200108)8:4<647:ICCIAO>2.0.ZU;2-S
Abstract
Cystatin C is an essential secretory cofactor for neurogenesis with potent protease inhibitor activities. Polymorphisms of cystatin C are genetically associated with Alzheimer's disease (AD), and the L68Q mutation causes here ditary cerebral hemorrhage with amyloidosis of the Icelandic type, in which cystatin C and beta -amyloid are colocalized in cortical blood vessels. To determine whether cystatin C and beta -amyloid also colocalize in brain am yloid plaques, we analyzed transgenic mice expressing the Swedish APP (SweA PP) mutation. We found high levels of cystatin C in astrocytes surrounding beta -amyloid plaques, and discrete layers of cystatin C attached to amyloi d plaque cores covered by a layer of beta -amyloid. In addition, cystatin C accumulated in reactive astrocytes throughout the brain, independently of, and before the onset of, amyloid plaque formation. These results show that expression of SweAPP is associated with increased cystatin C in reactive a strocytes, and they suggest an early role of cystatin C in appositional amy loid plaque growth. (C) 2001 Academic Press.